Publications

Note:  All articles are the sole copyright of the respective publishers.  Materials are provided for educational purposes only. Downloading of materials constitutes an agreement that the materials are for personal use only.

 

2022 _______________________________________________________

  1. Nieto, S. J., Grodin, E. N., Burnette, E. M., Cahill, C. M., & Ray, L. A. (2022). Pain Catastrophizing Is Associated With Increased Alcohol Cue-Elicited Neural Activity Among Individuals With Alcohol Use Disorder. Alcohol and Alcoholism.
  2. Grodin, E. N., Nieto, S. J., Meredith, L. R., Burnette, E., O’Neill, J., Alger, J., London, E. D., Miotto, K., Evans, C. J., Irwin, M. R., & Ray, L. A. (2022). Effects of ibudilast on central and peripheral markers of inflammation in alcohol use disorder: A randomized clinical trial. Addiction Biology, 27(4), e13182.
  3. Baskerville, W. A., Grodin, E. N., Venegas, A., & Ray, L. A. (2022). Global Sleep Quality is Associated with Tonic Craving, but Not Cue-Induced Craving. Addictive Behaviors, 107372.
  4. Leventhal, A. M., Cho, J., Ray, L. A., Liccardo Pacula, R., Lee, B. P., Terrault, N., Pederson, E., Lee, J. O., Davis, J. P., Jin, H., Huh, J., Wilson, J. P., & Whaley, R. C. (2022). Alcohol use trajectories among US adults during the first 42 weeks of the COVID‐19 pandemic. Alcoholism: clinical and experimental research.
  5. Nieto, S. J., Venegas, A., Hudson, J., & Ray, L. A. (2022). Cannabis use and subjective response to alcohol in the human laboratory. Drug and Alcohol Dependence, 236, 109481.
  6. Green, R., Roche, D. J., & Ray, L. A. (2022). The Effects of Menstrual Cycle Hormones on Responses to Varenicline and Naltrexone Among Female Heavy Drinking Smokers. Alcohol and Alcoholism.
  7. Nieto, S. J., & Ray, L. A. (2022). Applying the Addictions Neuroclinical Assessment to derive neurofunctional domains in individuals who use methamphetamine. Behavioural Brain Research, 427, 113876.
  8. Meredith, L. R., Grodin, E. N., Montoya, A. K., Miranda Jr, R., Squeglia, L. M., Towns, B., Evans, C., & Ray, L. A. (2022). The effect of neuroimmune modulation on subjective response to alcohol in the natural environment. Alcoholism: Clinical and Experimental Research.
  9. Grodin, E. N., Donato, S., Du, H., Green, R., Bujarski, S., & Ray, L. A. (2022). A Meta-Regression of Trial Features Predicting the Effects of Alcohol Use Disorder Pharmacotherapies on Drinking Outcomes in Randomized Clinical Trials: A Secondary Data Analysis. Alcohol and Alcoholism.
  10. Burnette, E. M., Nieto, S. J., Grodin, E. N., Meredith, L. R., Hurley, B., Miotto, K., Gillis, A. J., & Ray, L. A. (2022). Novel agents for the pharmacological treatment of alcohol use disorder. Drugs, 1-24.
  11. Ekhtiari, H., Zare-Bidoky, M., Sangchooli, A., Janes, A. C., Kaufman, M. J., Oliver, J. A., Ray, L. A., Prisciandaro, J. J., Wüstenberg, T., Anton, R. F., Bach, P., Baldacchino, A., Beck, A., Bjork, J. M., Brewer, J., Childress, A. R.,Claus, Courtney, K. E., Ebrahimi, M., Goudriaan, A. E., E. D…& Zilverstand, A. (2022). A methodological checklist for fMRI drug cue reactivity studies: development and expert consensus. Nature Protocols, 17(3), 567-595.
  12. Baskerville, W. A., Friedman, T. C., Hurley, B., Hsieh, S., Dixon, T., Mtume, N., Lee, M. L., Rodriguez, L., Lopez, B., & Ray, L. A. (2022). Embedding comprehensive smoking cessation programs into community clinics: study protocol for a cluster-randomized controlled trial. Trials, 23(1), 1-13.
  13. Nieto, S. J., Grodin, E. N., Ho, D., Baskerville, W. A., & Ray, L. A. (2022). Moderators of subjective response to alcohol in the human laboratory. Alcoholism: Clinical and Experimental Research, 46(3), 468-476.
  14. Nieto, S. J., Venegas, A., Burnette, E. M., MacKillop, J., & Ray, L. A. (2022). Additive roles of tobacco and cannabis co-use in relation to delay discounting in a sample of heavy drinkers. Psychopharmacology, 239(5), 1387-1395.

2021 _______________________________________________________

  1. Baskerville, W. A., Nieto, S. J., Ho, D., Towns, B., Grodin, E. N., Li, C., Li, C., Burnette, E., Donato, S., & Ray, L. A. (2021). Baseline Drinking Patterns in Non-Treatment Seeking Problem Drinkers. Alcohol and Alcoholism, 56(1), 57-63.
  2. Green, R., Montoya, A. K., & Ray, L. A. (2021). The relationship between drinking and smoking in a clinical trial for smoking cessation and drinking reduction. Experimental and Clinical Psychopharmacology.
  3. Meredith, L. R., Baskerville, W. A., Friedman, T. C., Hurley, B., Dixon, T., Mtume, N., Rodriguez, L., Lopez, B., Hsieh, S., & Ray, L. A. (2021). Safety Net Provider Attitudes Toward Smoking Cessation Treatment. Frontiers in Psychiatry, 12, 744816.
  4. Nieto, S. J., Grodin, E. N., Aguirre, C. G., Izquierdo, A., & Ray, L. A. (2021). Translational opportunities in animal and human models to study alcohol use disorder. Translational psychiatry, 11(1), 1-14.
  5. Burnette, E. M., Ray, L. A., Irwin, M. R., & Grodin, E. N. (2021). Ibudilast attenuates alcohol cue–elicited frontostriatal functional connectivity in alcohol use disorder. Alcoholism: Clinical and Experimental Research, 45(10), 2017-2028.
  6. Donato, S., Green, R., & Ray, L. A. (2021). Alcohol use disorder severity moderates clinical response to varenicline. Alcoholism: Clinical and Experimental Research, 45(9), 1877-1887.
  7. Venegas, A., Donato, S., Meredith, L. R., & Ray, L. A. (2021). Understanding low treatment seeking rates for alcohol use disorder: A narrative review of the literature and opportunities for improvement. The American Journal of Drug and Alcohol Abuse, 47(6), 664-679.
  8. Grodin, E. N., Burnette, E., Towns, B., Venegas, A., & Ray, L. A. (2021). Effect of alcohol, tobacco, and cannabis co-use on gray matter volume in heavy drinkers. Psychology of Addictive Behaviors, 35(6), 760.
  9. Meredith, L. R., Grodin, E. N., Karno, M. P., Montoya, A. K., MacKillop, J., Lim, A. C., & Ray, L. A. (2021). Preliminary study of alcohol problem severity and response to brief intervention. Addiction science & clinical practice, 16(1), 1-12.
  10. Meredith, L. R., Burnette, E. M., Grodin, E. N., Irwin, M. R., & Ray, L. A. (2021). Immune treatments for alcohol use disorder: A translational framework. Brain, Behavior, and Immunity, 97, 349-364.
  11. Leventhal, A. M., Conti, D. V., Ray, L. A., Baurley, J. W., Bello, M. S., Cho, J., Zhang, Y., Pester, M.S., Lebovitz, L., Budiarto, A., Mahesworo, B., & Pardamean, B. (2021). A genetic association study of tobacco withdrawal endophenotypes in African Americans. Experimental and Clinical Psychopharmacology.
  12. Grodin, E. N., Burnette, E. M., Green, R., Lim, A. C., Miotto, K., & Ray, L. A. (2021). Combined varenicline and naltrexone attenuates alcohol cue-elicited activation in heavy drinking smokers. Drug and Alcohol Dependence, 225, 108825.
  13. Ray, L. A., Green, R., & Grodin, E. (2021). Neurobiological models of alcohol use disorder in humans. American Journal of Psychiatry, 178(6), 483-484.
  14. Nieto, S. J., Baskerville, W., Donato, S., Bujarski, S., & Ray, L. (2021). Lifetime heavy drinking years predict alcohol use disorder severity over and above current alcohol use. The American Journal of Drug and Alcohol Abuse, 47(5), 630-637.
  15. Green, R., Du, H., Grodin, E. N., Nieto, S. J., Bujarski, S., Roche, D. J., & Ray, L. A. (2021). A meta‐regression of methodological features that predict the effects of medications on the subjective response to alcohol. Alcoholism: Clinical and Experimental Research, 45(7), 1336-1347.
  16. Grodin, E. N., Bujarski, S., Towns, B., Burnette, E., Nieto, S., Lim, A., Lin, J., Miotto, K., Gillis, A., Irwin, M. R., Evans, C., & Ray, L. A. (2021). Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial. Translational psychiatry, 11(1), 1-8.
  17. Ray, L. A., Green, R., Enders, C., Leventhal, A. M., Grodin, E. N., Li, G., Lim, A., Hartwell, E., Venegas, A., Meredith, L., Nieto, S. J., Shoptaw, S., Ho, D., & Miotto, K. (2021). Efficacy of combining varenicline and naltrexone for smoking cessation and drinking reduction: a randomized clinical trial. American Journal of Psychiatry, 178(9), 818-828.
  18. Mehta, K., Hoadley, A., Ray, L. A., Kiluk, B. D., Carroll, K. M., & Magill, M. (2021). Cognitive-behavioral interventions targeting alcohol or other drug use and co-occurring mental health disorders: a meta-analysis. Alcohol and Alcoholism, 56(5), 535-544.
  19. Mehta, K., Hoadley, A., Ray, L. A., Kiluk, B. D., Carroll, K. M., & Magill, M. (2021). ” Cognitive-behavioral interventions targeting alcohol or other drug use and co-occurring mental health disorders: A meta-analysis”: Erratum.
  20. Nieto, S. J., Grodin, E. N., Green, R., & Ray, L. A. (2021). Evaluation of the Addictions Neuroclinical Assessment (ANA) framework through deep phenotyping of problem drinkers. Drug and alcohol dependence, 221, 108603.
  21. Burnette, E. M., Grodin, E. N., Eisenberger, N. I., & Ray, L. A. (2021). Endotoxin for Alcohol Research: A Call for Experimental Medicine Using Lipopolysaccharide Challenge. Alcohol and Alcoholism, 56(6), 715-717.
  22. Ray, L. A., & Grodin, E. N. (2021). Clinical neuroscience of addiction: what clinical psychologists need to know and why. Annual Review of Clinical Psychology, 17, 465-493.
  23. Green, R., MacKillop, J., Hartwell, E. E., Lim, A. C., Baskerville, W. A., Karno, M., & Ray, L. A. (2021). Behavioral economic demand for alcohol and cigarettes in heavy drinking smokers: evidence of asymmetric cross-commodity reinforcing value. Nicotine and Tobacco Research, 23(4), 748-755.
  24. Ray, L. A., Du, H., Green, R., Roche, D. J., & Bujarski, S. (2021). Do behavioral pharmacology findings predict clinical trial outcomes? A proof-of-concept in medication development for alcohol use disorder. Neuropsychopharmacology, 46(3), 519-527.
  25. Burnette, E. M., Grodin, E. N., Ghahremani, D. G., Galvan, A., Kohno, M., Ray, L. A., & London, E. D. (2021). Diminished cortical response to risk and loss during risky decision making in alcohol use disorder. Drug and alcohol dependence, 218, 108391.
  26. Nieto, S. J., Green, R., Grodin, E. N., Cahill, C. M., & Ray, L. A. (2021). Pain catastrophizing predicts alcohol craving in heavy drinkers independent of pain intensity. Drug and alcohol dependence, 218, 108368.
  27. Burnette, E. M., Grodin, E. N., Schacht, J. P., & Ray, L. A. (2021). Clinical and neural correlates of reward and relief drinking. Alcoholism: Clinical and Experimental Research, 45(1), 194-203.
  28. Ray, L. A., Grodin, E. N., Leggio, L., Bechtholt, A. J., Becker, H., Feldstein Ewing, S. W., Jentsch, J. D., King, A. C., Mason, B. J., O’Malley S., Heilig, M., Koob, G. F., & MacKillop, J. (2021). The future of translational research on alcohol use disorder. Addiction Biology, e12903.
  29. Bello, M. S., Liautaud, M. M., De La Cerda, J. T., Pang, R. D., Ray, L. A., Ahluwalia, J. A., & Leventhal, A. M. (2021). Association of frequency of perceived exposure to discrimination with tobacco withdrawal symptoms and smoking lapse behavior in African Americans. Addiction, 116(4), 914-925.
  30. Venegas, A., Meredith, L. R., Green, R., Cooper, Z. D., & Ray, L. A. (2021). Sex-dependent effects of alcohol administration on the urge to use cannabis. Experimental and clinical psychopharmacology.

2020 _______________________________________________________

  1. Cummings, J. R., Ray, L. A., Nooteboom, P., & Tomiyama, A. J. (2020). Acute Effect of Eating Sweets on Alcohol Cravings in a Sample with At-Risk Drinking. Annals of Behavioral Medicine, 54(2), 132-138.
  2. Venegas, A., & Ray, L. A. (2020). Comparing alcohol cue-reactivity in treatment-seekers versus non-treatment-seekers with alcohol use disorder. The American journal of drug and alcohol abuse, 46(1), 131-138.
  3. Ray, L. A., Du, H., Grodin, E., Bujarski, S., Meredith, L., Ho, D., … & Wassum, K. (2020). Capturing habitualness of drinking and smoking behavior in humans. Drug and Alcohol Dependence, 207, 107738.
  4. Grodin, E. N., Nguyen, X. T., Ho, D., Bujarski, S., & Ray, L. A. (2020). Sensitivity and specificity of a commercial urinary ethyl glucuronide (ETG) test in heavy drinkers. Addictive Behaviors Reports, 100249.
  5. Aguirre, C. G., Stolyarova, A., Das, K., Kolli, S., Marty, V., Ray, L., … & Izquierdo, A. (2020). Sex-dependent effects of chronic intermittent voluntary alcohol consumption on attentional, not motivational, measures during probabilistic learning and reversal. bioRxiv.
  6. Nieto, S. J., Grodin, E. N., & Ray, L. A. (2020). On the path toward personalized medicine: implications of pharmacogenetic studies of alcohol use disorder medications. Expert Review of Precision Medicine and Drug Development, 5(1), 43-54.
  7. Glasner, S., Chokron Garneau, H., Ang, A., Ray, L., Venegas, A., Rawson, R., & Kalichman, S. (2020). Preliminary Efficacy of a Cognitive Behavioral Therapy Text Messaging Intervention Targeting Alcohol Use and Antiretroviral Therapy Adherence: A Randomized Clinical Trial. PloS one, 15(3), e0229557.
  8. Grodin, E., Montoya, A., Bujarski, S., & Ray, L. (2020). Modeling Motivation for Alcohol in Humans using Traditional and Machine Learning Approaches.
  9. Venegas, A., Meredith, L. R., Cooper, Z. D., Towns, B., & Ray, L. A. (2020). Inclusion of cannabis users in alcohol research samples: screening in, screening out, and implications. Alcohol and alcoholism.
  10. Lim, A. C., Grodin, E. N., Green, R., Venegas, A., Meredith, L. R., Courtney, K. E., … & Ray, L. A. (2020). Executive function moderates naltrexone effects on methamphetamine-induced craving and subjective responses. The American Journal of Drug and Alcohol Abuse, 1-12.
  11. Lim, A. C., Green, R., Grodin, E. N., Venegas, A., Meredith, L. R., Donato, S., … & Ray, L. A. (2020). Alcohol Cue–Induced Ventral Striatum Activity Predicts Subsequent Alcohol Self‐Administration. Alcoholism: Clinical and Experimental Research.
  12. Magill, M., Tonigan, J. S., Kiluk, B., Ray, L., Walthers, J., & Carroll, K. (2020). The search for mechanisms of cognitive behavioral therapy for alcohol or other drug use disorders: A systematic review. Behaviour Research and Therapy, 103648.
  13. Kramer, J., Dick, D. M., King, A., Ray, L. A., Sher, K. J., Vena, A., … & Acion, L. (2020). Mechanisms of Alcohol Addiction: Bridging Human and Animal Studies. Alcohol and Alcoholism, 55(6), 603-607.
  14. Grodin, E. N., Green, R., & Ray, L. A. (2020). An Exploratory Factor Analysis of the Stimulant, Sedative, and Affective Responses to Alcohol. Alcoholism: Clinical and Experimental Research, 44(11), 2298-2306.
  15. Nieto, S. J., Green, R., MacKillop, J., & Ray, L. A. (2020). Intravenous Alcohol Administration Selectively Decreases Rate of Change in Elasticity of Demand in Individuals with Alcohol Use Disorder. Alcoholism: Clinical and Experimental Research, 44(11), 2336-2342.
  16. Meredith, L. R., Lim, A. C., & Ray, L. A. (2020). Neurocognitive performance in alcohol use disorder using the NIH toolbox: Role of severity and sex differences. Drug and Alcohol Dependence, 216, 108269.
  17. Burnette, E. M., Baskerville, W. A., Grodin, E. N., & Ray, L. A. (2020). Ibudilast for alcohol use disorder: study protocol for a phase II randomized clinical trial. Trials, 21(1), 1-19.
  18. Ho, D., Towns, B., Grodin, E. N., & Ray, L. A. (2020). A novel human laboratory model for screening medications for alcohol use disorder. Trials, 21(1), 1-13.
  19. Burnette, E. M., Grodin, E. N., Ghahremani, D. G., Galvan, A., Kohno, M., Ray, L. A., & London, E. D. (2020). Diminished cortical response to risk and loss during risky decision making in alcohol use disorder. Drug and alcohol dependence, 108391.
  20. Nieto, S. J., Green, R., Grodin, E. N., Cahill, C. M., & Ray, L. A. (2020). Pain catastrophizing predicts alcohol craving in heavy drinkers independent of pain intensity. Drug and alcohol dependence, 218, 108368.
  21. Ray, L. A., Du, H., Green, R., Roche, D. J., & Bujarski, S. (2020). Do behavioral pharmacology findings predict clinical trial outcomes? A proof-of-concept in medication development for alcohol use disorder. Neuropsychopharmacology, 1-9.
  22. Green, R., MacKillop, J., Hartwell, E. E., Lim, A. C., Baskerville, W. A., Karno, M., & Ray, L. A. (2020). Behavioral Economic Demand for Alcohol and Cigarettes in Heavy Drinking Smokers: Evidence of Asymmetric Cross-commodity Reinforcing Value. Nicotine & Tobacco Research.

2019 _______________________________________________________

  1. Grodin, E.N., Ray, L.A., MacKillop, J., Lim, A.C., & Karno, M.P. (2019) Elucidating the Effect of a Brief Drinking Intervention Using Neuroimaging: A Preliminary Study. Alcoholism: Clinical and Experimental Research, 43(2), 367-377.
  2. Green, R., Bujarski, S., Lim, A.C., Venegas, A., & Ray, L.A. (2019) Naltrexone and alcohol effects on craving for cigarettes in heavy drinking smokers. Experimental and Clinical Psychopharmacology, 27(3), 257-264.
  3. Falk, D. E., Ryan, M. L., Fertig, J. B., Devine, E. G., Cruz, R., Brown, E. S., … & Galloway, G. (2019). Gabapentin Enacarbil Extended‐Release for Alcohol Use Disorder: A Randomized, Double‐Blind, Placebo‐Controlled, Multisite Trial Assessing Efficacy and Safety. Alcoholism: Clinical and Experimental Research, 43(1), 158-169.
  4. Green, R., Grodin, E., Lim, A. C., Venegas, A., Bujarski, S., Krull, J., & Ray, L. A. (2019). The interplay between subjective response to alcohol, craving, and alcohol self‐administration in the human laboratory. Alcoholism: Clinical and Experimental Research, 43(5), 907-915.
  5. Grodin, E. N., Courtney, K. E., & Ray, L. A. (2019). Drug-Induced Craving for Methamphetamine Is Associated With Neural Methamphetamine Cue Reactivity. Journal of studies on alcohol and drugs, 80(2), 245-251.
  6. Ray, L. A., Lim, A. C., & Shoptaw, S. (2019). What defines a clinically meaningful outcome in the treatment of substance use disorders:‘Getting your life back’. Addiction, 114(1), 18-20.
  7. Ray, L. A., Bujarski, S., Grodin, E., Hartwell, E., Green, R., Venegas, A., … & Miotto, K. (2019). State-of-the-art behavioral and pharmacological treatments for alcohol use disorder. The American journal of drug and alcohol abuse, 45(2), 124-140.
  8. Roche, D. J. O., Bujarski, S., Green, R., Hartwell, E. E., Leventhal, A. M., & Ray, L. A. (2019). Alcohol, tobacco, and marijuana consumption is associated with increased odds of same-day substance co-and tri-use. Drug and alcohol dependence, 200, 40-49.
  9. Grodin, E. N., & Ray, L. A. (2019). The Use of Functional Magnetic Resonance Imaging to Test Pharmacotherapies for Alcohol Use Disorder: A Systematic Review. Alcoholism: Clinical and Experimental Research, 43(10), 2038-2056.
  10. Kiluk, B. D., Ray, L. A., Walthers, J., Bernstein, M., Tonigan, J. S., & Magill, M. (2019). Technology‐Delivered Cognitive‐Behavioral Interventions for Alcohol Use: A Meta‐Analysis. Alcoholism: clinical and experimental research, 43(11), 2285-2295.
  11. Grodin, E. N., Bujarski, S., Venegas, A., Baskerville, W. A., Nieto, S. J., Jentsch, J. D., & Ray, L. A. (2019). Reward, Relief and Habit Drinking: Initial Validation of a Brief Assessment Tool. Alcohol and Alcoholism, 54(6), 574-583.
  12. Hartwell, E. E., Bujarski, S., Green, R., & Ray, L. A. (2019). Convergence between the Penn Alcohol Craving Scale and diagnostic interview for the assessment of alcohol craving.Addictive Behaviors Reports, 10, 100198.
  13. Burnette, E. M., Grodin, E. N., Lim, A. C., MacKillop, J., Karno, M. P., & Ray, L. A. (2019). Association between impulsivity and neural activation to alcohol cues in heavy drinkers. Psychiatry Research: Neuroimaging, 293, 110986.
  14. Magill, M., Ray, L., Kiluk, B., Hoadley, A., Bernstein, M., Tonigan, J. S., & Carroll, K. (2019). A meta-analysis of cognitive-behavioral therapy for alcohol or other drug use disorders: Treatment efficacy by contrast condition. Journal of consulting and clinical psychology, 87(12), 1093.
  15. Ray, L. A., Green, R., Roche, D. J., Magill, M., & Bujarski, S. (2019). Naltrexone effects on subjective responses to alcohol in the human laboratory: A systematic review and meta‐analysis. Addiction biology, 24(6), 1138-1152.
  16. Cummings, J. R., Gearhardt, A. N., Ray, L. A., Choi, A. K., & Tomiyama, A. J. (2019). Experimental and observational studies on alcohol use and dietary intake: a systematic review. Obesity Reviews.
  17. Cortland, C. I., Shapiro, J. R., Guzman, I. Y., & Ray, L. A. (2019). The ironic effects of stigmatizing smoking: combining stereotype threat theory with behavioral pharmacology. Addiction, 114(10), 1842-1848.
  18. Lim, A. C., Ghahremani, D. G., Grodin, E. N., Green, R., Bujarski, S., Hartwell, E. E., … & Ray, L. A. (2019). Neuroimaging findings from an experimental pharmacology trial of naltrexone in heavy drinkers of East Asian descent. Drug and alcohol dependence, 200, 181-190.
  19. Grodin, E. N., Lim, A. C., MacKillop, J., Karno, M. P., & Ray, L. A. (2019). An Examination of Motivation to Change and Neural Alcohol Cue Reactivity Following a Brief Intervention. Frontiers in psychiatry, 10, 408.

2018 _______________________________________________________

  1. Garneau, H. C., Venegas, A., Rawson, R., Ray, L. A., & Glasner, S. (2018). Barriers to initiation of extended release naltrexone among HIV-infected adults with alcohol use disorders. Journal of Substance Abuse Treatment, 85, 34-37.
  2. Hartwell, E.E., & Ray, L.A. (2018). Craving as a DSM-5 symptom of alcohol use disorder in non-treatment seekers. Alcohol & Alcoholism, 14, 1-6.
  3. Ray, L.A., Green, R., Roche, D.J.O., Bujarski, S., Hartwell, E., Lim, A., Rohrbaugh, T., Ghahremani, D., Hutchison, K.E., Miotto, K. (2018). Pharmacogenetic effects of naltrexone in individuals of East Asian descent: Human Laboratory Findings from a Randomized Trial. Alcoholism: Clinical and Experimental Research, 42(3), 613-623.
  4. Moallem, N.R., Courtney, K.E., & Ray, L.A. (2018). The relationship between impulsivity and methamphetamine use severity in a community sample. Drug and Alcohol Dependence, 187, 1-7.
  5. Green, R. & Ray, L.A. (2018). Effects of varenicline on subjective craving and relative reinforcing value of cigarettes. Drug and Alcohol Dependence, 188, 53-59.
  6. Hartwell, E. & Ray, L.A. (2018). Relationship between tonic and phasic craving for alcohol. Addictive Behavior Reports, 7, 71-74.
  7. Bujarski, S., Jentsch, J.D., Roche, D.J.O., Ramchandani, V.A., Miotto, K., & Ray, L.A. (2018) Differences in the subjective and motivational properties of alcohol across alcohol use disorder severity: application of a novel translational human laboratory paradigm. Neuropsychopharmacology, 43(9), 1891-1899.
  8. Ray, L. A., & Roche, D.J.O. (2018). Neurobiology of Craving: Current Findings and New Directions. Current Addiction Reports, 5(2), 102-109.
  9. Cummings, J. R., Tomiyama, A. J., & Ray, L.A. (2018). Does the Neuroimmune Modulator Ibudilast Alter Food Craving? Results in a Sample With Alcohol Use Disorder. Journal of Addiction Medicine. 12(5), 410-417.
  10. Bello, M.S., McBeth, J.F., Ditre, J.W., Kirkpatrick, M.G., Ray, L.A., Dunn, K.E., & Leventhal, A.M. (2018). Pain as a predictor and consequence of tobacco abstinence effects amongst African American smokers. Journal of Abnormal Psychology, 127(7) 683-694.
  11. Allen, V.C., Ray, L.A., & Myers, H.F. (2018). Examining the Sexual Health Consequences of Alcohol Consumption Among Black Gay and Bisexual Men. Alcoholism: Clinical & Experimental Research, 42(8), 1548-1555.
  12. Ray, L.A., Bujarski, S., Roche, D.J.O., & Magill, M. (2018) Overcoming the “Valley of Death” in medications development for alcohol use disorder. Alcoholism: Clinical & Experimental Research, 42(9), 1612-1622.
  13. Lim, A.C., Courtney, K.E., Moallem, N.R., Allen, V.C., Leventhal, A.M., & Ray, L.A. (2018) A brief smoking cessation intervention for heavy drinking smokers: Treatment development, feasibility, and preliminary results. Frontiers in Psychiatry, 9, 362.
  14. Lim, A.C., Roche, D.J.O., & Ray, L.A. (2018) Distress tolerance and craving for cigarettes among heavy drinking smokers. Journal of Studies on Alcohol and Drugs, 79(6), 918-928.
  15. Ray, L.A., Bujarski, S., Grodin, E.N., Hartwell, E.E., Green, R., & Venegas, A. (2018) State-of-the-art behavioral and pharmacological treatments for alcohol use disorder. The American Journal of Drug and Alcohol Abuse, 1-17. 

2017 _______________________________________________________

  1. Bujarski, S., Hutchison, K.E., Prause, N., & Ray, L.A. (2017). Functional Significance of Subjective Response to Alcohol across Levels of Alcohol Exposure. Addiction Biology, 22(1), 235-45.
  2. Cservenka, A. & Ray, L.A. (2017). Self-reported attentional and motor impulsivity are related to age at first methamphetamine use. Addictive Behaviors, 65, 7-12.
  3. Cummings, J.R., Ray, L.A., & Tomiyama, A.J. (2017). Food-alcohol competition: As young females eat more food, do they drink less alcohol? Journal of Health Psychology, 22(5), 674-683.
  4. Yardley, M., & Ray, L.A. (2017). Medications development for the treatment of alcohol use disorder: Insights into the predictive value of animal paradigms and human laboratory models. Addiction Biology, 22(3), 581-615.
  5. Bello, M.S., Pang, R.D., Chasson, G.S., Ray, L.A., & Leventhal, A.M. (2017). Obsessive-Compulsive Symptoms and Negative Affect During Tobacco Withdrawal in a Non-Clinical Sample of African American Smokers. Journal of Anxiety Disorders, 48, 78-86. 
  6. Cservenka, A., Yardley, M.M., & Ray, L.A. (2017). Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity. The American Journal on Addictions, 26(5), 516-525. 
  7. Bullock, K., Cservenka, A., & Ray, L.A. (2017). Severity of alcohol dependence is negatively related to hypothalamic and prefrontal cortical gray matter density in heavy drinking smokers. American Journal of Drug and Alcohol Abuse, 43(3), 281-290.
  8. Westman, J., Bujarski, S.E., & Ray, L.A. (2017). Impulsivity moderates subjective responses to alcohol in alcohol dependent individuals. Alcohol & Alcoholism, 52(2), 249-255.
  9. Lim, A., Cservenka, A., & Ray, L.A. (2017). Effects of alcohol dependence severity on neural correlates of delay discounting. Alcohol & Alcoholism, 52(4), 506-515. 
  10. Ray, L.A., Bujarski, S.E., Shoptaw, S., Roche, D.J.O., Heinzerling, K., & Miotto, K. (2017). Development of the neuroimmune modulator ibudilast for the treatment of alcoholism: A randomized, placebo-controlled, human laboratory trial. Neuropsychopharmacology, 42, 1776-1788. 
  11. Ray, L.A., Bujarski, S., Yardley, M.M., Roche, D.J.O., & Hartwell, E. (2017). Differences between treatment-seeking and non-treatment seeking participants in medication studies for alcoholism: Do they matter? American Journal of Drug and Alcohol Abuse, 43, 703-710.
  12. Roche, D.J.O., Worley, M., Courtney, K., Bujarski, S., London, E., Shoptaw, S., Ray, L.A. (2017). Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder. Psychopharmacology, 234(13), 1997-2007.
  13. Cservenka, A., Courtney, K., Ghahremani, D., Hutchison, K.E., & Ray, L.A. (2017). Development, initial testing, and challenges of an ecologically valid reward prediction error fMRI task for alcoholism. Alcohol & Alcoholism, 52(5), 617-624. 

2016 _______________________________________________________

  1. Ray, L.A., Bujarski, S., & Roche D.J.O. (2016) Subjective Response to Alcohol as a Research Domain Criterion. Alcoholism: Clinical and Experimental Research, 40(1), 6-17.
  2. Squeglia, L. M., Brammer, W. A., Ray, L. A., & Lee, S. S. (2016). Attention-deficit/hyperactivity disorder (ADHD) symptoms predict alcohol expectancy development. Journal of Child and Adolescent Substance Abuse, 25(2), 169-179.
  3. Moore, A.A., Karno, M.P., Ray, L.A., Ramirez, K., Barenstein, V., Portillo, M., Rizo, P., Borok, J., Liao, D.H., Barron, J., Del Pino, H.E., Valenzuela, A., Barry, K.L. (2016). Development and preliminary testing of a promotora-delivered, Spanish language, counseling intervention for unhealthy drinking among male, Latino day laborers. Journal of Substance Abuse Treatment, 62, 96-101.
  4. Inagaki, T.K., Ray, L.A., Irwin, M.R., Way, B.M., Eisenberger, N.I. (2016). Opioids and social bonding: Naltrexone reduces feelings of social connection. Social Cognitive and Affective Neuroscience, 11(5), 728-735.
  5. Courtney, K.E., & Ray, L.A. (2016). Clinical neuroscience of amphetamine-type stimulants: From basic science to treatment development. Progress in Brain Research, 223, 295-310.
  6. Bacio, G.A. & Ray, L.A. (2016). Patterns of drinking initiation among Latino youths: Cognitive and contextual explanations of the immigrant paradox. Journal of Child & Adolescent Substance Abuse, 1-11.
  7. Roche, D.J.O., Ray, L.A., Yardley, M.M., & King, A.C. (2016). Current insights into the mechanisms and treatments for heavy-drinking cigarette smokers. Current Addiction Reports, 3(1), 125-137.
  8. Roche, D.J.O., Lunny, K.F., Yardley, M.M., Louie, S.G., Davies, D.L., Miotto K., & Ray L.A. (2016). A Pilot study of the safety and initial efficacy of ivermectin for the treatment of alcohol use disorder. Alcoholism: Clinical and Experimental Research, 40(6), 1312-1320.
  9. Green, R., Bujarski, S., Roche, D.J.O., & Ray, L.A. (2016). Relationship between negative affect and smoking topography in heavy drinking smokers. Addictive Behaviors, 61, 53-57.
  10. Chung, T., Noronha, A., Carroll, K.M., Potenza, M.N., Hutchison, K., Calhoun, V.D., Gabrieli, J.D.E., Morgenstern, J., Nixon, S.J., Wexler, B.E., Brewer, J., Ray, L.A., Filbey, F., Strauman, T.J., Kober, H., & Feldstein Ewing, S.W. (2016). Brain Mechanisms of Change in Addiction Treatment: Models, Methods, and Emerging Findings. Current Addiction Reports, 3(3), 332-342.
  11. Bujarski, S. & Ray, L.A. (2016). Experimental psychopathology paradigms for alcohol use disorder: Applications for translational research. Behaviour Research and Therapy, 86, 11-22.
  12. Courtney, K.E., Ghahremani, D.G., & Ray, L.A. (2016). The effects of pharmacological opioid blockade on neural measures of drug cue-reactivity in humans. Neuropsychopharmacology, 41(12), 2872-2881.
  13. Hartwell, E.E., Moallem, N.R., Courtney, K.E., Glasner-Edwards, S., & Ray, L.A. (2016). Sex differences in the association between internalizing symptoms and craving in methamphetamine users. Journal of Addiction Medicine, 10(6), 395-401.

2015 _______________________________________________________

  1. Roche D.J.O., Ray L.A. (2015). Subjective response as a consideration in the pharmacogenetics of alcoholism treatment. Pharmacogenomics, 16(7), 721-36.
  2. Owens, M., Ray, L.A., & MacKillop, J. (2015). Behavioral economic analysis of stress effects on acute motivation for alcohol. Journal of the Experimental Analysis of Behavior, 103(1), 77-86.
  3. Bujarski, S., Hutchison, K.E., Roche, D.J.O. & Ray, L.A. (2015). Factor Structure of Subjective Responses to Alcohol in Light and Heavy Drinkers. Alcoholism: Clinical and Experimental Research, 39(7), 1193-1202. 
  4. Roche D.J.O., Bujarski S, Hartwell E, Green R, & Ray L.A. (2015). Combined Varenicline and Naltrexone Treatment reduces Smoking Topography Intensity in Heavy-Drinking Smokers. Pharmacology, Biochemistry and Behavior, 134, 92-98. 
  5. Ray, L.A., Bujarski, S.E., Courtney, K.E., Moallem, N.R., Lunny, K., Roche, D.J.O., Leventhal, A.,Shoptaw, S., Heinzerling, K., London, E.D., & Miotto, K. (2015). The effects of naltrexone on subjective response to methamphetamine in a clinical sample: A double-blind, placebo-controlled, laboratory study. Neuropsychopharmacology, 1-10.
  6. Sheets, E.S., Bujarski, S., Leventhal, A., & Ray, L.A. (2015) Emotion Differentiation and Intensity during Acute Tobacco Abstinence: A Comparison of Heavy and Light Smokers. Addictive Behaviors. 47, 70-73.
  7. Bujarski, S., Roche, D.J.O., Sheets, E.S., Krull, J.L., Guzman I., & Ray, L.A. (2015) Modeling naturalistic craving, withdrawal, and affect during early nicotine abstinence: a pilot EMA study. Experimental and Clinical Psychopharmacology. 23(2) 81 – 89.
  8. Allen, V. Myers, H.F., & Ray, L.A. (2015). The association between alcohol consumption and condom use: Considering correlates of HIV risk among Black men who have sex with men. AIDS & Behavior, 19(9), 1689-1700.
  9. Bidwell, L.C., Knopik, V.S., Audrain-McGovern,J., Glynn, T.R., Spillane, N.S., Ray, L.A., Riggs, N.R., Guillot, C., Pang,R.D., & Leventhal, A.M. (2015). Novelty seeking as a phenotypic marker of adolescent substance use. Substance Abuse: Research and Treatment, 9(Suppl 1), 1-10.
  10. Yardley, M.M., Mirbaba, M.M., & Ray, L.A. (2015). Pharmacological options for smoking cessation in heavy-drinking smokers. CNS Drugs, 29(10), 833-845.
  11. Hartwell, E.E., Bujarski, S., Glasner-Edwards, S., & Ray, L.A. (2015). The association of alcoholism severity with sleep quality in problem alcohol users. Alcohol & Alcoholism, 50(5), 536-541.
  12. Ray, L.A., Courtney, K., Ghahremani, D., Miotto, K., Brody, A. & London, E.D. (2015). Varenicline, naltrexone, and their combination for heavy drinking smokers: Preliminary neuroimaging findings. American Journal of Drug and Alcohol Abuse, 41(1), 35-44.
  13. Courtney, K.E., Ghahremani, D.G., & Ray, L.A. (2015). The effect of alcohol priming on neural markers of alcohol cue-reactivity. American Journal of Drug and Alcohol Abuse, 41(4), 300-308.
  14. Bujarski, S.E., Lau, A., Lee, S., & Ray, L.A. (2015). Genetic and environmental predictors of alcohol use in Asian American young adults. Journal of Studies on Alcohol and Drugs, 76(5), 690-699.
  15. Ray, L.A. & Bujarski,S.E. (2015). Mechanisms of topiramate effects: Refining medications development for alcoholism. Addiction Biology, 21(1), 183-84.

2014 _______________________________________________________

  1. Ray, L.A., Roche, D., Heinzerling, K., & Shoptaw, S. (2014). Opportunities for the development of neuroimmune therapies in addiction. International Review of Neurobiology, 118, 381-401.
  2. Courtney, K. & Ray, L.A. (2014). Subjective response to alcohol in the lab predicts neural response to alcohol cues. Journal of Studies on Alcohol and Drugs, 75(1), 124-35.
  3. Bacio, G.A., Lunny, K.F., Webb, J.N., & Ray, L.A. (2014). Alcohol use following and alcohol challenge and a brief intervention among alcohol-dependent individuals. American Journal on Addiction, 23(1), 96-101.
  4. Bacio, G.A., Moore, A., Karno, M., & Ray, L.A. (2014). Determinants of problem drinking and depression among Latino day laborers. Substance Use & Misuse, 49(8), 1039-1048.
  5. Miranda Jr., R., Monti, P.M., Ray, L.A., Treloar, H.R., Reynolds, E.K., Ramirez, J., Chun, T., Gwaltney, C.J., Justus, A., Tidey, J., Blanchard, A., & Magill, M. (2014). Characterizing subjective responses to alcohol among adolescent problem drinkers. Journal of Abnormal Psychology, 123(1), 117-29.
  6. Ray, L.A., Bujarski, S., Squeglia, L.M., Ashenhurst, J.R., & Anton, R. (2014). Interactive effects of OPRM1 and DAT1 genetic variation on subjective responses to alcohol. Alcohol & Alcoholism, 49(3), 261-270.
  7. DeMartini, K.S., Devine, E., DiClemente, C., Martin, D., Ray, L.A., & O’Malley, S.S. (2014). Predictors of pre-treatment commitment to abstinence: Results from the COMBINE Trial. Journal of Studies on Alcohol and Drugs, 75(3), 438-446.
  8. MacKillop, J., Amlung, M.T., Acker, J., Gray, J.C., Brown, C.L., Murphy, J.G., Ray, L.A., & Sweet, L.H. (2014). The neuroeconomics of alcohol demand: an initial investigation of the neural correlates of alcohol cost-benefit decision making in heavy drinking men. Neuropsychopharmacology, 39(8), 1988-1995.
  9. Roche, D.J.O., Bujarski, S., Moallem, N., Guzman, I., Shapiro, J., & Ray, L.A. (2014). Predictors of smoking lapse in a human laboratory paradigm. Psychopharmacology, 231(14). 2889-2897.
  10. Courtney, K., Ghahremani, D., London, E.D., & Ray, L.A. (2014). The association between cue reactivity in the precuneus and level of dependence on nicotine and alcohol. Drug and Alcohol Dependence, 141, 21-26.
  11. Bujarski, S. & Ray, L.A. (2014). Subjective response to alcohol and associated craving in heavy drinkers vs. alcohol dependents: An examination of Koob’s allostatic model in humans. Drug and Alcohol Dependence, 140, 161-167.
  12. Ashenhurst, J.R., Bujarski, S., Jentsch, J.D., & Ray, L.A. (2014). Modeling behavioral reactivity to losses and rewards on the Balloon Analogue Risk Task (BART): Moderation by alcohol problem severity. Experimental and Clinical Psychopharmacology, 22(4), 298-306.
  13. Ray, L.A., Courtney, K., Ghahremani, D., Miotto, K., Brody, A., & London, E.D. (2014). Varenicline, low dose naltrexone, and their combination for heavy drinking smokers: Human laboratory findings. Psychopharmacology, 231, 3843-3853.
  14. Bacio, G.A., Guzman, I.Y., Shapiro, J.R., & Ray, L.A. (2014). Differences in quit attempts between Black and White daily smokers: the role of smoking motives. Addictive Behaviors, 39, 1769-1772.
  15. Bujarski, S., Roche, D., Lunny, K., Moallem, N.R., Courtney, K.E., Allen, V., Hartwell, E., Leventhal, A., Rohrbaugh, T., & Ray, L.A. (2014). The relationship between methamphetamine and alcohol use in a community sample of methamphetamine users. Drug and Alcohol Dependence, 142, 127-132.
  16. Courtney, K.E. & Ray, L.A. (2014). Methamphetamine: An update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. Drug and Alcohol Dependence, 143, 11-21.
  17. Sujan, A. C., Humphreys, K. L., Ray, L. A., & Lee, S. S. (2014). Differential association of child abuse with self-reported versus laboratory-based impulsivity and risk-taking in young adulthood. Child Maltreatment, 19(3-4), 145-155.
  18. Bujarski, S. & Ray, L.A. (2014). Negative affect is associated with alcohol, but not cigarette use in heavy drinking smokers. Addictive Behaviors, 39, 1723-1729.
  19. Miranda Jr., R., Ray, L.A., Blanchard, A., Reynolds, E.K., Monti, P.M., Chun, T., Justus, A., Swift, R. M., Tidey, J., Gwaltney, C.J., & Ramirez, J. (2013). Effects of naltrexone on adolescent alcohol cue-reactivity and sensitivity: An initial randomized trial. Addiction Biology, 19(5), 941-954.

2013 _______________________________________________________

  1. Miranda, R. Jr., Reynolds, E., Ray, L.A., Justus, A., Knopik, V.S., McGeary, J., & Meyerson, L.A. (2013). Preliminary evidence for a gene-environment interaction in predicting alcohol use disorders in adolescents. Alcoholism: Clinical and Experimental Research, 37(2), 325-331.
  2. Ray, L.A., Bujarski, S., MacKillop, J., Courtney, K.E., Monti, P.M., & Miotto, K. (2013). Sensitivity to alcohol among alcohol-dependent individuals: the effects of the μ-opioid receptor (OPRM1) gene and alcoholism severity. Alcoholism: Clinical and Experimental Research, 37(1), E116-E124.
  3. Bujarski, S., O’Malley, S., Lunny, K.N., & Ray, L.A. (2013). The effects of drinking goal on treatment outcome for alcoholism. Journal of Consulting and Clinical Psychology, 81(1), 13-22.
  4. Courtney, K.E., Ghahremani, D., & Ray, L.A. (2013). Fronto-striatal functional connectivity during response inhibition in alcohol dependence. Addiction Biology, 18(3), 593-604.
  5. Ray, L.A., Lunny, K., Bujarski, S., Moallem, N., Krull, J.L., & Miotto, K. (2013). The effects of varenicline on stress-induced and cue-induced craving for cigarettes. Drug and Alcohol Dependence, 131(1-2), 136-142.
  6. Courtney, K.E., Ashenhurst, J., Bacio, G., Moallem, N., Bujarski, S., Hartwell, E., & Ray, L.A. (2013). Subjective response to alcohol and alcohol craving: Validation of the Desires for Alcohol Questionnaire (DAQ) in the human lab. Journal of Studies on Alcohol and Drugs, 74(5), 797-802.
  7. Ray, L.A., Sehl, M., Bujarski, S., Hutchison, K.E., Blaine, S., & Enoch, M. (2013). The CRHR1 gene, trauma exposure, and alcoholism risk: A test of G × E effects. Genes, Brain & Behavior, 12(4), 361-36.
  8. Hartwell, E. & Ray, L.A. (2013). Sex moderates stress reactivity in heavy drinkers. Addictive Behaviors, 38(11), 2643-2646. 
  9. Moallem, N.R., Courtney, K.E., Bacio, G.A., & Ray, L.A. (2013). Modeling alcoholism severity: An integrative structural equation modeling approach. Frontiers in Psychiatry, 4:75. 
  10. Ray, L.A., Courtney, K., Hutchison, K.E., MacKillop, J., Galvan, A., & Ghahremani, D. (2013). Initial evidence that OPRM1 genotype moderates ventral and dorsal striatum functional connectivity during alcohol cues. Alcoholism: Clinical and Experimental Research, 38(1), 78-89.
  11. Lin, J.C., Karno, M.P., Grella, C.E., Ray, L.A., Liao, D.H., & Moore, A.A. (2013) Psychiatric correlates of alcohol and tobacco use disorders in U.S. adults aged 65 and older: Results from the 2001-2002 National Epidemiologic Survey of Alcohol and Related Conditions. American Journal of Geriatric Psychiatry, S1064-7481(13)00308-4.

2012 _______________________________________________________

  1. Heinzerling, K.G., McCracken, J.T., Swanson, A.N., Ray, L.A., Shoptaw, S.J. (2012). COMT Val158Met, BDNF Val66Met, and OPRM1 Asn40Asp, and methamphetamine dependence treatment response: Preliminary Investigations. Journal of Clinical Psychopharmacology, 32(1):135-137.
  2. Moallem, N. & Ray, L.A. (2012). Quetiapine improves response inhibition in alcohol dependent patients: A placebo-controlled pilot study. Pharmacology, Biochemistry, and Behavior, 100(3), 490-493.
  3. Ray, L.A., Courtney, K.E., Bujarski, S., & Squeglia, L.M. (2012). Pharmacogenetics of alcoholism: a clinical neuroscience perspective. Pharmacogenomics, 13(2), 129-132.
  4. Ray, L.A., Bujarski, S., Chin, P.F., & Miotto, K. (2012). Pharmacogenetics of naltrexone in Asian Americans: A randomized placebo-controlled laboratory study. Neuropsychopharmacology, 37(2), 445-455.
  5. Ray, L. A., Barr, C.S., Blendy, J.A., Oslin, D., Goldman, D., & Anton, R.F. (2012). The role of the Asn40Asp polymorphism of the mu opioid receptor (OPRM1) gene on alcoholism etiology and treatment: a critical review. Alcoholism: Clinical and Experimental Research, 36(3), 385-394.
  6. Courtney, K.E., Arellano, R., Barkley-Levenson, E., Gálvan, A., Poldrack, R.A., MacKillop, J., Jentsch, J.D., & Ray, L.A. (2012). The relationship between measures of impulsivity and alcohol misuse: an integrative structural equation modeling approach. Alcoholism: Clinical and Experimental Research, 36(6), 923-31.
  7. Leventhal, A.M., Ray, L.A., Rhee, S.H., & Unger, J.B. (2012). Genetic and environmental influences on the association between depressive symptom dimensions and smoking initiation among Chinese adolescent twins. Nicotine & Tobacco Research, 14(5), 559-68.
  8. MacKillop, J., Amlung, M., Wier, L., David, S., Ray, L.A., Bickell, W., & Sweet, L.H. (2012). The neuroeconomics of nicotine dependence: A preliminary study of delay discounting of monetary and cigarette rewards in smokers using fMRI. Psychiatry Research, 202(1), 20-29.
  9. Plebani, J., Ray, L.A., Morean, M.E., Corbin, W.R., MacKillop, J., Amlung, M., King, A.C. (2012). Human laboratory paradigms in alcohol research. Alcoholism: Clinical and Experimental Research, 36(6), 972-983.
  10. Bujarski, S., MacKillop, J., & Ray, L.A. (2012). Understanding naltrexone mechanism of action and pharmacogenetics in asian americans via behavior economics: A preliminary study. Experimental and Clinical Psychopharmacology, 20(3), 181-190.
  11. Moallem, N. & Ray, L.A. (2012). Dimensions of impulsivity among heavy drinkers, smokers, and heavy drinking smokers: singular and combined effects. Addictive Behaviors, 37(7), 871-874.
  12. Tartter, M. & Ray, L.A. (2012). A prospective study of laboratory-based stress and alcohol craving in heavy drinkers. Pharmacology, Biochemistry, and Behavior, 101(4), 625-631.
  13. Ray, L. A. (2012). Clinical neuroscience of addiction: Applications to psychological science and practice. Clinical Psychology: Science and Practice, 19(2), 154-166.
  14. Ashenhurst, J.R., Bujarski, S., & Ray, L.A. (2012). Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol. Pharmacology, Biochemistry, and Behavior, 103(2), 253-259.
  15. Bholat, M.A., Ray, L.A., Brensilver, M., Ling, K., & Shoptaw, S. (2012). Integration of behavioral medicine in primary care. Primary Care, 39(4), 605-614.

2011 _______________________________________________________

  1. Ray, L.A. (2011). Stress-induced and cue-induced craving for alcohol in heavy drinkers: Preliminary evidence of genetic moderation by the OPRM1 and CRH-BP genes. Alcoholism: Clinical and Experimental Research, 35(1), 166-174.
  2. Ray, L.A., Hart, E., Chin, P.F. (2011). Self-rating of the effects of alcohol (SRE): Predictive utility and reliability across interview and self-report administrations. Addictive Behaviors, 36(3), 241-3.
  3. Ray, L.A., Hart, E., Chelminski, I., Young, D., & Zimmerman, M. (2011). Clinical correlates of desire for treatment for current alcohol dependence in patients with a primary psychiatric disorder. American Journal of Drug and Alcohol Abuse, 37(2), 105-110.
  4. Ferriter, C. & Ray, L.A. (2011). Binge eating and binge drinking: an integrative review. Eating Behaviors, 12(2), 99-107.
  5. MacKillop, J., Amlung, M. T., Few, L.R., Ray, L.A., Sweet, L.H., Munafo, M.R. (2011). Delayed reward discounting and addictive behavior: a meta-analysis. Psychopharmacology, 216(3), 305-21.
  6. Hutchison, K.E. & Ray, L.A. (2011). New approaches to identifying rare genetic variants associated with nicotine dependence. Biological Psychiatry, 70(6) 500-501.
  7. Ray, L.A., Chin, P.F., Heydari, A., & Miotto, K. (2011). A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol craving. Psychopharmacology, 317(3), 341-351.
  8. Tartter, M. & Ray, L.A. (2011). The serotonin transporter polymorphism (5-HTTLPR) and alcohol problems in heavy drinkers: moderation by depressive symptoms. Frontiers in Psychiatry, 2:49, 1-7.
  9. Ashenhurst, J., Jentsch, J.D., & Ray, L.A. (2011). Risk-taking and alcohol use disorders symptomatology in a sample of problem drinkers. Experimental and Clinical Psychopharmacology, 19(5), 361-70.

2010 _______________________________________________________

  1. Miranda, R., Ray, L.A., Justus, A., Meyerson, L.A., Knopik, V.S., McGeary, J., & Monti, P.M. (2010). Initial evidence of an association between OPRM1 gene and adolescent alcohol misuse. Alcoholism: Clinical and Experimental Research, 34(1), 1-11.
  2. MacKillop, J., Miranda, R., Jr., Monti, P. M., Ray, L. A., Murphy, J.G., Rohsenow, D. J., McGeary, J. E., Swift, R. M., Tidey, J. W., & Gwaltney, C. J. (2010) Alcohol demand, delayed reward discounting, and craving in relation to drinking and alcohol use disorders. Journal of Abnormal Psychology, 119 (1), 106-114.
  3. Ray, L.A., Miranda Jr., R., Tidey, J.W., McGeary, J.E., MacKillop, J., Gwaltney, C.J., Rohsenow, D.J., Swift, R.M., & Monti, P.M. (2010). Polymorphisms of the μ-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environment. Journal of Abnormal Psychology, 119 (1), 115-125.
  4. Ray, L.A., Chin, P.F., & Miotto, K. (2010). Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics. CNS & Neurological Disorders – Drug Targets, 9 (1), 13-22.
  5. Ray, L.A., MacKillop, J., & Monti, P. (2010). Subjective responses to alcohol consumption as endophenotypes: advancing genetics into etiological and treatment models of alcoholism. Substance Use & Misuse, 45(11), 1742-1765.
  6. Ray, L.A., Hutchison, K.E., & Tartter, M. (2010). Application of human laboratory models to pharmacotherapy development for alcohol dependence. Current Pharmaceutical Design, 16(19), 2149-2158.
  7. Ray, L.A., Heydari, A., & Zorick, T. (2010). Quetiapine for the treatment of alcoholism: scientific rationale and review of the literature. Drug and Alcohol Review, 29(5), 568-575.
  8. MacKillop, J., O’Hagen, S., Lisman, S.A., Murphy, J.G., Ray, L.A., McGeary, J.E., Tidey, J.W., & Monti, P.E. (2010). Behavioral economic analysis of cue-elicited craving for alcohol. Addiction, 105(9), 1599-607.
  9. Ray, L.A., Hutchison, K.E., Ashenhurst, J., & Morrow, A.L. (2010). Naltrexone selectively elevates GABAergic neurosteroid levels in heavy drinkers with the Asp40 allele of the OPRM1 gene: a pilot investigation. Alcoholism: Clinical and Experimental Research, 34(8), 1479-1487.
  10. Ray, L.A., Krull, J.L., Leggio, L. (2010). The effects of naltrexone among alcohol non-abstainers: Results from the COMBINE Study. Frontiers in Psychiatry, 10:3389.
  11. Leventhal, A., Brightman, M., Ameringer, K.J., Greenberg, J., Mickens, L., Ray, L.A., & Sussman, S. (2010). Anhedonia associates with stimulant use and dependence in a population-based sample of American adults. Experimental and Clinical Psychopharmacology, 18(6), 562-569.

2009 _______________________________________________________

  1. Filbey, F., Ray, L.A., Smolen, A., Claus, E., Audette, A., & Hutchison, K.E. (2009). Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotype. Alcoholism: Clinical and Experimental Research, 32(7), 1113-1123.
  2. Ray, L.A., Bryan, A., MacKillop, J., McGeary, J., Hesterberg, K. & Hutchison, K.E. (2009). The Dopamine D4 receptor (DRD4) gene exon III polymorphism, problematic alcohol use, and novelty seeking: direct and mediated genetic effects. Addiction Biology, 14(2), 238-244.
  3. MacKillop, J., Murphy, J.G., Tidey, J., Kahler, C., Ray, L.A., & Bickel, W. (2009). Latent structure of the facets of alcohol reinforcement from a behavioral economic demand curve. Psychopharmacology, 203(1), 33-40.
  4. Ray, L.A., MacKillop, J., Leggio, L., Morgan, M., & Hutchison, K.E. (2009). Effects of naltrexone on cortisol levels in heavy drinkers. Pharmacology, Biochemistry, and Behavior, 91, 489-494.
  5. Leventhal, A.M., Kahler, C.W., Ray, L.A., & Zimmerman, M. (2009). Refining the depression-nicotine dependence link: patterns of depressive symptoms in psychiatric outpatients with current, past, and no history of nicotine dependence. Addictive Behaviors, 34(3), 297-303.
  6. Ray, L.A., Miranda, R., Jr., MacKillop, J., McGeary, J. E., Tidey, J. W., Rohsenow, D. J., Gwaltney, C. J., Swift, R. M., & Monti, P. M. (2009). A preliminary pharmacogenetic investigation of adverse events from topiramate in heavy drinkers. Experimental and Clinical Psychopharmacology, 17,122-129.
  7. Ray, L.A., Hutchison, K.E., Leventhal, A., Miranda, R. Jr., Francione, C., Young, D., Chelminski, I., & Zimmerman, M. (2009). Diagnosing alcohol abuse in alcohol dependent individuals: diagnostic and clinical implications. Addictive Behaviors, 34, 587-592.
  8. Magill, M., & Ray, L.A. (2009). Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. Journal of Studies on Alcohol and Drugs, 70, 516-527.
  9. Ray, L.A., & Hutchison, K.E. (2009). Associations among GABRG1, level of response to alcohol, and drinking behaviors. Alcoholism: Clinical and Experimental Research, 33(8), 1382-1390.
  10. Leggio, L., Ray, L.A., Kenna, G., and Swift, R.M. (2009). Blood glucose level, alcohol heavy drinking, and alcohol craving during treatment for alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study. Alcoholism: Clinical and Experimental Research, 33(9), 1539-1544.
  11. Leventhal, A.M., Waters, A.J., Kahler, C.W., Ray, L.A., & Sussman, S. (2009). Relations between anhedonia and smoking motivation. Nicotine & Tobacco Research, 11(9), 1047-1054.
  12. Witkiewitz, K., Holmes, A., Ray, L.A., Murphy, J.G., Richardson, H.N., Chen, Y.-C., McDevitt-Murphy, M.E., Cruz, M.T., & Roberto, M. (2009). Young investigator award symposium. Alcohol, 43, 499-508.
  13. Ray, L.A., MacKillop, J., Leventhal, A., & Hutchison, K.E. (2009) Catching the alcohol buzz: an examination of the latent factor structure of subjective intoxication. Alcoholism: Clinical and Experimental Research, 33(12), 2154-2161.
  14. Ray, L.A., & Oslin, D.W. (2009). Naltrexone for the treatment of alcohol dependence among African Americans: Results from the COMBINE Study. Drug and Alcohol Dependence, 105(3), 256-258.
  15. Ray, L.A., Capone, C., Sheets, E., Young, D., Chelminski, I., & Zimmerman, M. (2009). Posttraumatic stress disorder with and without alcohol use disorders: diagnostic and clinical correlates in a psychiatric sample. Psychiatry Research, 170 (2-3), 278-281.

2008 _______________________________________________________

  1. Miranda, R. Jr., Rohsenow, D.J., Monti, P.M., Tidey, J., & Ray, L.A. (2008). Effects of repeated days of smoking cue-exposure on urge to smoke and physiological reactivity. Addictive Behaviors, 33(2), 347-353.
  2. Miranda, R. Jr., MacKillop J., Monti, P.M., Rohsenow, D.J., Tidey, J., Gwaltney, C., Swift, R., Ray, L.A., & McGeary, J.E. (2008). Effects of topiramate on urge to drink and the subjective effects of alcohol : A preliminary laboratory study. Alcoholism: Clinical and Experimental Research, 32(3), 489-497.
  3. Leventhal, A.M., Kahler, C.W., Ray, L.A., Stone, K., & Zimmerman, M. (2008). Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder. American Journal on Addictions, 17(3), 218-223.
  4. Ray, L.A., Miranda Jr., R., Young, D., Chelminski, I., & Zimmerman, M. (2008). Diagnostic orphans for alcohol use disorders in a treatment-seeking psychiatric sample. Drug and Alcohol Dependence, 96(1-2), 187-191.
  5. MacKillop, J., Murphy, J.G., Ray, L.A., Eisenberg, D.T.A., Lisman, S.A., Lum, J.K., & Wilson, D.S. (2008). Further validation of the cigarette purchase task for assessing the relative reinforcing efficacy of nicotine in college smokers. Experimental and Clinical Psychopharmacology, 16(1), 57-65.
  6. Ray, L.A., Kahler, C., Young, D., Chelminski, I., & Zimmerman, M. (2008). The factor structure and severity of DSM-IV alcohol abuse and dependence symptoms in psychiatric outpatients. Journal of Studies on Alcohol and Drugs, 69(4), 496-499.
  7. Ray, L.A., Hutchison, K.E., MacKillop, J., Miranda, R. Jr., Audette, A., Swift, R., & Monti, P.M. (2008). Effects of naltrexone during the descending limb of the blood alcohol curve. American Journal on Addictions, 17(4), 257-264.
  8. Haughey, H.M., Ray, L.A., Finan, P., Villanueva, R., Nicolescu, M., & Hutchison, K.E. (2008). Human gamma-aminobutyric acid A receptor alpha2 gene moderates the acute effects of alcohol and brain mRNA expression. Genes, Brain, and Behavior, 7(4), 447-454.

2007 _______________________________________________________

  1. Bryan, A., Ray, L.A., & Cooper, M.L. (2007). Alcohol use and protective sexual behaviors among high-risk adolescents: A prospective analysis. Journal of Studies on Alcohol and Drugs, 68(3), 327-335.
  2. Ray, L.A., Meskew-Stacer, S., & Hutchison, K.E. (2007). The relationship between prospective self-rating of alcohol sensitivity and craving and experimental results from two alcohol challenge studies. Journal of Studies on Alcohol and Drugs, 68(3), 379-384.
  3. Ray, L.A., Rhee, S.H., Stallings, M.S., Knopik, V., & Hutchison, K.E. (2007). Examining the heritability of a laboratory-based smoking endophenotype: Initial Results from an experimental twin study. Twin Research and Human Genetics, 10(4), 546-553.
  4. Ray, L.A., Miranda, R. Jr., Kahler, C.M., Leventhal, A.M., Monti, P.M., Swift, R., & Hutchison, K.E. (2007). Pharmacological effects of naltrexone and intravenous alcohol on craving for cigarettes: A pilot study. Psychopharmacology, 193(4), 449-456.
  5. Ray, L.A., & Hutchison, K.E. (2007). Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: A double-blind placebo-controlled study. Archives of General Psychiatry, 64(9), 1069-1077.
  6. Ray, L.A., MacKillop, J., & Hutchison, K.E. (2007). Pharmacogenetics of the μ-opioid receptor and the treatment of addictions. Personalized Medicine, 4(2), 217-220.

2006 _______________________________________________________

  1. Hutchison, K.E., Ray, L.A., Sandman, E., Rutter, M.C., Peters, A., & Swift, R. (2006). The effect of olanzapine on craving and alcohol consumption. Neuropsychopharmacology, 31, 1310-1317.
  2. Ray, L.A., McGeary, J., Marshall, E., & Hutchison, K.E. (2006). Risk factors for alcohol misuse: Examining heart rate response to alcohol, alcohol sensitivity, and personality constructs. Addictive Behaviors, 31(11), 1959-1973.
  3. Ray, L.A., Hutchison, K.E., & Bryan, A. (2006). Psychosocial predictors of treatment outcome, dropout, and change processes in a pharmacological clinical trial for alcohol dependence. Addictive Disorders and Their Treatment, 5(4), 179-190.

2005 _______________________________________________________

  1. Hines, L., Ray, L.A., Hutchison, K.E., & Tabakoff, B. (2005). Alcoholism: The dissection for endophenotypes. Dialogues in Clinical Neuroscience, 7(3), 153-163.

2004 _______________________________________________________

  1. Ray, L.A., & Hutchison, K. E. (2004). A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. Alcoholism: Clinical and Experimental Research, 28, 1789-1795.
  2. Fromme, K., de Witt, H., Hutchison, K.E., Ray, L.A., Corbin, W.R., Cook, T.A., & Wall, T.L. (2004). Biological and behavioral markers of alcohol sensitivity. Alcoholism: Clinical and Experimental Research, 28(2), 247-256.